Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CagriSema is an investigational weight loss injection combining semaglutide 2.4 mg (a GLP-1 agonist, the drug in Wegovy) and cagrilintide 2.4 mg (an amylin analogue)
Research applications focus on body composition optimization, energy expenditure, and metabolic health protocols particularly around visceral fat reduction and metabolic efficiency
This product is a research reagent intended exclusively for in-vitro laboratory research and experimental use by qualified professionals
Even then, peptide drugs remained limited by delivery challenges, Kates said
avoid repeated freezethaw cycles Keep vials tightly closed until use and follow standard peptide handling procedures Detailed COA and batch information can be shared for qualified B2B customers Related Products DSIP sleep and stress-support peptide kit Browse the Sleep & Stress Support Peptides range Browse all Nootropic & Anti-Aging Peptides Wholesale Custom peptide and OEM project support from our China-based factory team THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
